Symeres

Symeres is a prominent contract research organization (CRO) established in 1988, specializing in comprehensive drug discovery and development services. Operating within the business services sector, the firm provides high-level R&D support to the global pharmaceutical and biotechnology industries. By integrating advanced medicinal chemistry with preclinical drug discovery capabilities, Symeres facilitates the transition of molecules from early-stage research into clinical development. The organization leverages its extensive expertise to support major pharma partners in navigating complex drug development pipelines, ensuring best-in-class outcomes for diverse therapeutic programs.

The company maintains a robust operational footprint with 4 locations across Europe, including facilities in the Netherlands, Czech Republic, Finland, and Sweden. With a workforce ranging from 500-1,000 employees, Symeres emphasizes a multidisciplinary approach to scientific innovation. Meet Symeres's team to understand the organizational structure and the specialized talent driving their research initiatives. This scale allows the firm to manage large-scale projects while maintaining the agility required for specialized medicinal chemistry and drug development tasks. The company’s infrastructure is designed to support complex R&D workflows, ensuring consistent delivery across all stages of the drug discovery lifecycle.

Symeres generates annual revenue of $15.8M, reflecting its established position as a key service provider in the European CRO market. The firm focuses on delivering high-quality, data-driven results for clients engaged in clinical stage drug development. By combining technical precision with a deep understanding of pharmaceutical requirements, Symeres continues to advance its service offerings in the competitive biotechnology landscape.